Arsenic-Associated Oxidative Stress, Inflammation, and Immune Disruption in Human Placenta and Cord Blood

• Published in: Environmental health perspectives 2011-02, Vol.119 (2), p.258-264
• Main Authors: Ahmed, Sultan, Khoda, Sultana Mahabbat-e, Rekha, Rokeya Sultana, Gardner, Renee M., Ameer, Syeda Shegufta, Moore, Sophie, Ekström, Eva-Charlotte, Vahter, Marie, Raqib, Rubhana
• Format: Article
• Language: English
• Subjects: 8-oxoguanine; Arsenic; Arsenic - toxicity; Arsenic - urine; Biological and medical sciences; Blood; Chemical and industrial products toxicology. Toxic occupational diseases; Children's Health; Cord blood; Cytokines; Diseases; Diseases of mother, fetus and pregnancy; Environment. Living conditions; Female; Fetal Blood - drug effects; Fetal Blood - immunology; Fetal Blood - metabolism; Gynecology. Andrology. Obstetrics; Health; Health aspects; Humans; Infants; Infants (Newborn); Inflammation - chemically induced; leptin; Markers; Matlab; Medical sciences; MEDICIN; MEDICINE; Metals and various inorganic compounds; Oxidative stress; Oxidative Stress - drug effects; P values; Placenta; Placenta - drug effects; Placenta - immunology; Placenta - metabolism; Pregnancy; Pregnancy. Fetus. Placenta; Pregnant women; Public health. Hygiene; Public health. Hygiene-occupational medicine; Randomized Controlled Trials as Topic; Risk factors; Rope; Stresses; T lymphocytes; Toxicology; Urine
• ISSN: 0091-6765; 1552-9924; 1552-9924
• DOI: 10.1289/ehp.1002086

Background: Arsenic (As) exposure during pregnancy induces oxidative stress and increases the risk of fetal loss and low birth weight. Objectives: In this study we aimed to elucidate the effects of As exposure on immune markers in the placenta and cord blood, and the involvement of oxidative stress. Methods: Pregnant women were enrolled around gestational week (GW) 8 in our longitudinal, population-based, mother-child cohort in Matlab, an area in rural Bangladesh with large variations in As concentrations in well water. Women (n = 130) delivering at local clinics were included in the present study. We collected maternal urine twice during pregnancy (GW8 and GW30) for measurements of As, and placenta and cord blood at delivery for assessment of immune and inflammatory markers. Placental markers were measured by immunohistochemistry, and cord blood cytokines by multiplex cytokine assay. Results: In multivariable adjusted models, maternal urinary As (U-As) exposure both at GW8 and at GW30 was significantly positively associated with placental markers of 8-oxoguanine (8-oxoG) and interleukin-lβ (IL-1β); U-As at GW8, with tumor necrosis factor-α (TNFα) and interferon-γ (IFNγ); and U-As at GW30, with leptin; U-As at GW8 was inversely associated with CD3⁺ T cells in the placenta. Cord blood cytokines (IL-Iβ, IL-8, IFNγ, TNFα) showed a U-shaped association with U-As at GW30. Placental 8-oxoG was significantly positively associated with placental proinflammatory cytokines. Multivariable adjusted analyses suggested that enhanced placental cytokine expression (TNFα and IFNγ) was primarily influenced by oxidative stress, whereas leptin expression appeared to be mostly mediated by As, and IL-Iβ appeared to be influenced by both oxidative stress and As. Conclusion: AS exposure during pregnancy appeared to enhance placenta! inflammatory responses (in part by increasing oxidative stress), reduce placental T cells, and alter cord blood cytokines. These findings suggest that effects of As on immune function may contribute to impaired fetal and infant health.